Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Standard BioTools Inc.

    NASDAQ: FLDM · Real-Time Price · USD
    3.71
    -0.28 (-7.02%)
    At close: Apr 06, 2022, 6:00 AM

    Standard BioTools Revenue Breakdown

    Period Ending Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
    Consumables Revenue 57.88M 6.76M 45.41M 48.16M
    Consumables Revenue Growth +756.69% -85.12% -5.70% n/a
    Grant Revenue 1.58M 99.94M 50M 45.49M
    Grant Revenue Growth -98.42% +99.87% +9.92% n/a
    Instruments Revenue 42.5M 22.58M n/a n/a
    Instruments Revenue Growth +88.22% n/a n/a n/a
    License Revenue 147K n/a 95.42M 93.65M
    License Revenue Growth n/a n/a +1.89% n/a
    Product and Service, Other Revenue 1.73M n/a 21.28M 19.31M
    Product and Service, Other Revenue Growth n/a n/a +10.16% n/a
    Product Revenue 100.38M n/a n/a n/a
    Product Revenue Growth n/a n/a n/a n/a
    Service Revenue 25.92M n/a n/a n/a
    Service Revenue Growth n/a n/a n/a n/a

    Revenue by Geography

    Period Ending Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
    Americas Revenue 63.88M 74.59M 47.02M 51.17M 20M 18.48M 10.93M 12.88M 6.56M
    Americas Revenue Growth -14.36% +58.64% -8.12% +155.80% +8.26% +69.14% -15.17% +96.19% n/a
    Asia Pacific Revenue 23.98M 25.78M 30.2M 25.18M n/a n/a n/a n/a n/a
    Asia Pacific Revenue Growth -6.98% -14.64% +19.97% n/a n/a n/a n/a n/a n/a
    Emea Revenue 42.72M 37.78M 40.02M 36.62M n/a n/a n/a n/a n/a
    Emea Revenue Growth +13.09% -5.62% +9.30% n/a n/a n/a n/a n/a n/a

    Operating Expense Breakdown

    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
    Selling, General, and Administrative Revenue 19.22M 38.71M 37.59M 34.4M 37.67M 46.94M 21.35M 22.29M 22.6M 22.31M 23.9M 29.6M 30.38M 30.88M 22.96M 24.07M 24.25M 27.61M 31.93M 22.66M 20.62M 22.7M 18.79M 20.73M 22.13M 22.82M 21.97M 20.02M 18.99M 18.8M 15.86M 20.1M 20.98M 22.58M 22.77M 21.12M 23.84M 25.48M 22.09M 19.56M 21.22M 20.09M
    Selling, General, and Administrative Revenue Growth -50.34% +2.98% +9.26% -8.68% -19.75% +119.83% -4.21% -1.36% +1.31% -6.67% -19.24% -2.59% -1.59% +34.47% -4.62% -0.73% -12.17% -13.55% +40.96% +9.89% -9.16% +20.78% -9.35% -6.35% -3.02% +3.88% +9.75% +5.44% +0.97% +18.55% -21.09% -4.16% -7.09% -0.85% +7.79% -11.42% -6.40% +15.35% +12.92% -7.84% +5.61% n/a
    Research and Development Revenue 334K 11.33M 14.05M 13.16M 19.22M 15.98M 6.91M 6.37M 6.18M 6.41M 8.38M 8.65M 12.61M 8.87M 8.54M 9.21M 9.44M 10.75M 11.19M 8.13M 8.45M 8.7M 8.28M 7.13M 7.87M 8.37M 7.96M 7.43M 7.39M 7.26M 7.16M 7.68M 7.46M 8.52M 8.77M 9.25M 9.98M 10.41M 9.74M 9.44M 10.09M 9.99M
    Research and Development Revenue Growth -97.05% -19.39% +6.82% -31.56% +20.29% +131.29% +8.46% +3.01% -3.51% -23.49% -3.16% -31.38% +42.20% +3.79% -7.25% -2.46% -12.20% -3.87% +37.62% -3.79% -2.89% +5.09% +16.18% -9.41% -6.06% +5.20% +7.11% +0.60% +1.79% +1.37% -6.83% +2.98% -12.47% -2.84% -5.18% -7.28% -4.17% +6.90% +3.13% -6.40% +1.00% n/a

    Add to Watchlist